TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
TELA Bio, Inc. reported a Q3 loss of $0.42 per share, missing the Zacks Consensus Estimate of a $0.37 loss. This is a slight improvement from the $0.45 loss per share a year ago.
November 08, 2024 | 12:30 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TELA Bio, Inc. reported a Q3 loss of $0.42 per share, which was worse than the expected loss of $0.37 per share. This may negatively impact the stock price in the short term.
The reported loss per share of $0.42 was worse than the expected $0.37, indicating underperformance. This typically leads to a negative reaction in the stock market as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100